Cosentyx and cognition?

Cosentyx (secukinumab) is a monoclonal antibody that blocks IL‑17A and is used for psoriasis, psoriatic arthritis, and ankylosing spondylitis (and related conditions).

When you say “Cosentyx and cognition,” there are a few angles—what are you noticing: memory/brain fog changes, attention issues, mood/cognition, or something else?

What we know about cognition

• Direct “cognitive impairment” is not a well-established or common side effect of Cosentyx in the way it is for some other medicines (like sedatives).
• Some people with inflammatory conditions experience cognitive symptoms indirectly (e.g., fatigue, depression, anxiety, sleep disturbance, pain), and improving inflammation can sometimes improve how someone feels mentally.
• That said, individual experiences vary, and there can be related effects such as:
  • fatigue
  • headache
  • mood changes (less commonly reported)
  • sleep disruption (which can affect cognition)

Important safety note (rare but relevant)

If you develop neurologic symptoms (not just mild brain fog), it’s worth prompt medical advice—especially:

• new/worsening weakness, numbness
• vision changes
• confusion
• severe or persistent headache
• signs of infection (fever, severe chills), since infections can affect cognition

Quick questions so I can tailor the answer

1. What cognitive change are you concerned about (memory, attention, “brain fog,” confusion)?
2. When did it start relative to your Cosentyx dose (days/weeks/months)?
3. Which condition are you treating (psoriasis/PsA/AS), and are you on any other meds (e.g., steroids, methotrexate, antidepressants)?
4. Any other symptoms (fatigue, headaches, mood changes, sleep issues)?

If you tell me those, I can help you think through likely causes, what to monitor, and what to ask your prescriber.